Efficacy And Safety Of Adalimumab Biosimilar (Exemptia) In Moderate-To-Severe Steroid-Refractory Ulcerative Colitis Patients: Real-Life Outcomes In Resource-Constrained Setting At 24-Weeks Follow-Up
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 24, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - August 30, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Remicade & reg; & nbsp;(infliximab): & nbsp;20 years of contributions to science and medicine
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 30, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Clinical utility of ramucirumab in non-small-cell lung cancer
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 21, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Therapeutic drug monitoring of biologics in psoriasis
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 5, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Antitumor and antibacterial properties of virally encoded cationic sequences
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - June 25, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - June 14, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
